Ignite Creation Date:
2025-12-25 @ 4:08 AM
Ignite Modification Date:
2026-02-10 @ 10:31 AM
Study NCT ID:
NCT02720120
Status:
TERMINATED
Last Update Posted:
2016-03-28
First Post:
2016-03-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Rheumatoid Arthritis | View |
Keywords: